Last updated on April 2017

A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal Lozenges [Menthol] and ANTI-ANGIN FORMULA Lozenges in Treatment of Patients With a Sore Throat


Brief description of study

The purpose of this study is to evaluate no less therapeutic efficacy and safety of the Angal, lozenges [Menthol], 1 mg + 5 mg (Sandoz dd, Slovenia) compared to ANTI-ANGIN® FORMULA, lozenges, 0,2 mg + 2 mg + 50 mg (LLC "Valeant", Russia) in treatment of patients with uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat.

Clinical Study Identifier: NCT03095521

Contact Investigators or Research Sites near you

Start Over

Sandoz

Sandoz Investigational Site
Moscow, Russian Federation
0.42miles
  Connect »